20 June 2013
Keywords: phytopharm, new, obesity, drug, deal, pfizer, uk-based
Article | 05 August 2002
UK-based Phytopharm has reached a new deal with Pfizer on thedevelopment of its cactus-derived antiobesity drug P57. The drug is
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
5 August 2002
19 June 2013
© 2013 thepharmaletter.com